Is Heartbeam Inc. Common Stock a good investment? Heartbeam Inc. Common Stock (BEAT) is currently trading at 0.3917 USD. Market analysts have a consensus price target of 3.13 USD. This suggests a potential upside from current levels.
Earnings Schedule: Heartbeam Inc. Common Stock is expected to release its next earnings report on March 18, 2027. The market consensus estimate for Forward EPS is -0.53.
No, it does not currently pay a dividend.
Heartbeam Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be March 18, 2027. The company currently has a trailing EPS of -0.39.
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart's electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Community Discussion